Welcome to the IKCEST

Molecular Therapy: Methods & Clinical Development | Vol.2, Issue.C | 2017-05-23 | Pages

Molecular Therapy: Methods & Clinical Development

Testing gene therapy vectors in human primary nasal epithelial cultures

Jing Wu,Huibi Cao,Hong Ouyang,Wan Ip,Kai Du,Wenming Duan,Julie Avolio,Cathleen Duan,Herman Yeger,Christine E Bear,Tanja Gonska,Jim Hu,Theo J Moraes  
Abstract

Cystic fibrosis (CF) results from mutations in the CF transmembrane conductance regulator (CFTR) gene, which codes for a chloride/bicarbonate channel in the apical epithelial membranes. CFTR dysfunction results in a multisystem disease including the development of life limiting lung disease. The possibility of a cure for CF by replacing defective CFTR has led to different approaches for CF gene therapy; all of which ultimately have to be tested in preclinical model systems. Primary human nasal epithelial cultures (HNECs) derived from nasal turbinate brushing were used to test the efficiency of a helper-dependent adenoviral (HD-Ad) vector expressing CFTR. HD-Ad-CFTR transduction resulted in functional expression of CFTR at the apical membrane in nasal epithelial cells obtained from CF patients. These results suggest that HNECs can be used for preclinical testing of gene therapy vectors in CF.

Original Text (This is the original text for your reference.)

Testing gene therapy vectors in human primary nasal epithelial cultures

Cystic fibrosis (CF) results from mutations in the CF transmembrane conductance regulator (CFTR) gene, which codes for a chloride/bicarbonate channel in the apical epithelial membranes. CFTR dysfunction results in a multisystem disease including the development of life limiting lung disease. The possibility of a cure for CF by replacing defective CFTR has led to different approaches for CF gene therapy; all of which ultimately have to be tested in preclinical model systems. Primary human nasal epithelial cultures (HNECs) derived from nasal turbinate brushing were used to test the efficiency of a helper-dependent adenoviral (HD-Ad) vector expressing CFTR. HD-Ad-CFTR transduction resulted in functional expression of CFTR at the apical membrane in nasal epithelial cells obtained from CF patients. These results suggest that HNECs can be used for preclinical testing of gene therapy vectors in CF.

+More

Cite this article
APA

APA

MLA

Chicago

Jing Wu,Huibi Cao,Hong Ouyang,Wan Ip,Kai Du,Wenming Duan,Julie Avolio,Cathleen Duan,Herman Yeger,Christine E Bear,Tanja Gonska,Jim Hu,Theo J Moraes,.Testing gene therapy vectors in human primary nasal epithelial cultures. 2 (C),.

References

Disclaimer: The translated content is provided by third-party translation service providers, and IKCEST shall not assume any responsibility for the accuracy and legality of the content.
Translate engine
Article's language
English
中文
Pусск
Français
Español
العربية
Português
Kikongo
Dutch
kiswahili
هَوُسَ
IsiZulu
Action
Recommended articles

Report

Select your report category*



Reason*



By pressing send, your feedback will be used to improve IKCEST. Your privacy will be protected.

Submit
Cancel